Enbrel ex-McKinsey nerd

























Ken Song, M.D., President and CEO of RayzeBio, said, “Despite therapeutic advances in recent years, the need for more effective treatments in solid tumors persists, and radiopharmaceutical therapeutics are positioned to be an important next wave of innovation in oncology therapy. Bristol Myers Squibb’s well-established presence in oncology and deep expertise in developing, commercializing and manufacturing treatments on a global scale makes it the ideal partner for RayzeBio at this important moment in our evolution. I am excited to see what our team achieves as part of Bristol Myers Squibb.”
 
























Funny how the Caltech site puts his description:

“An Asian man with coiffed hair and rectangular glasses, wearing a blue polo shirt “Jay Chiang. Entrepreneur in Residence, Life Sciences.
 
























Funny how the brother without the MIT degree and McKinsey pedigree works for Flagship Pioneering and is a COO of one of their startups. Younger bro is taller and less nerdy looking too.